{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Lexington",
      "address_1": "1040 Manchester St",
      "reason_for_recall": "The firm information that the product was reporting false positive results",
      "address_2": "",
      "product_quantity": "10/1 mL vials",
      "code_info": "Lot # 5072543 Exp Date 03/12/2021; UDI : 10634853000039.",
      "center_classification_date": "20180213",
      "distribution_pattern": "Distributed to the states of AL, AZ & MS.",
      "state": "KY",
      "product_description": "Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE.  Catalog 200265    Intended for identification of the systemic fungal pathogens.",
      "report_date": "20180221",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Gibson Laboratories LLC",
      "recall_number": "Z-0606-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "78731",
      "termination_date": "20180220",
      "more_code_info": "",
      "recall_initiation_date": "20170120",
      "postal_code": "40508-2422",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}